Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

ANTH 2.50 -0.05 (-1.96%)
price chart
Trader's Buzz: Anthera Pharmaceuticals (ANTH), Kite Pharma (KITE), 3D ...
Anthera Pharmaceuticals (ANTH) is seeing a big move Monday, as the company's shares are up 34% on optimism regarding its symposium on Systemic Lupus Erythematosus (SLE) at 3:30 PM on Wednesday, January 14th at the Mystic Hotel in San ...
Related articles »  
Short Interest of Anthera Pharmaceuticals Inc Drops by 13.7%
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) reported a drop of 13.7% or 59,890 shares in its short interest. The short figure came in at 1.8% of the total floats.
Underperforming Companies for the Week: Liberty Interactive Corp , Anthera ...  Winston View
Anthera Pharmaceuticals Inc Analyst Rating Update
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) has received a Neutral rating from research analysts at Zacks with a rank of 3. The company has been rated an average of 1 by 2 Wall Street Analysts.
Shares Outperform S&P Index: Anthera Pharmaceuticals Inc , Vectren Corp  Rock Hill Daily
The Four Best Stocks So Far in 2014: Arena Pharmaceuticals, (ARNA), Anthera ...  Investor Wired (press release)
Anthera Pharmaceuticals Announces Appointment of Klara A. Dickinson as ...
7, 2015 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced the appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer.
Anthera Pharmaceuticals Inc. Files SEC Form SC 13G, Statement of Acquisition ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S.
Anthera jumps as interest in lupus med builds (ANTH)
Thinly-traded nano cap Anthera Pharmaceuticals (ANTH +32.6%) jumps on a bullish 16x surge in volume. The company has a symposium on systemic lupus erythematosus scheduled for next week in San Francisco.
The 52-Week Low Club for Friday
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) dropped about 2.3% on Friday to a new 52-week low of $2.33. Share volume is about equal to the daily average of around 127,000.
Related articles »  
Can the Uptrend Continue for Anthera Pharmaceuticals (ANTH)?
Investors certainly have to be happy with Anthera Pharmaceuticals Inc (ANTH - Snapshot Report) and its short term performance.
Can the Uptrend Continue for Anthera Pharmaceuticals (ANTH)? - Tale of the Tape  Nasdaq
Anthera Pharmaceuticals, Inc. (ANTH) Posts Q1 Loss of 39c/Share
Additional information and publications from the CHABLIS-SC1 clinical study can be found at
Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and ...  MarketWatch
Related articles »  
Investor Alert: Monsanto Company (NYSE:MON), Accenture Plc (NYSE:ACN ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) has been one of top under-performers in trade this year. The stock has been forming lower lows and lower highs which is indicative of the fact that bears are using all rallies in the stock as a selling ...